ARTHRITIS
INTRODUCTION
SEROPOSITIVE ?
RA FACTOR
Anti-CCP antibodies
RF assosciations
Rheumatoid Arthritis
Peak 20-55yrs
M:F = 1:3
RADIOLOGICAL FINDINGS
X-RAYS
1.
Soft-tissue changes
2.
Osteoporosis
3.
4.
Periostitis
5.
Erosions
6.
Secondary osteoarthritis
Swelling due to
1.
2.
3.
metacarpophalangeal joints
ulnar styloid (invl of ext carpi ulnaris tendon)
radial styloid (invl of radiocarpal synovial hypertrophy)
Foot
OSTEOPOROSIS
Types
1.
2.
EROSIONS
In Hand
1.
2.
3.
4.
In Foot
1.
2.
3.
4.
B. Erosions.Note the erosion from the extensor carpi ulnaris (rat bite
lesion) (arrow) and prestyloid recess (arrowhead). Note the adjacent
erosion on the triquetral bone (crossed arrow).
PERIOSTEITIS
Local periosteal reactions occur either along the
midshaft of a phalanx or metacarpal as a reaction to
local tendinitis, at the metaphysis near a joint
affected by synovitis.
Such changes are less common in rheumatoid arthritis
than in the seronegative arthropathies
SECONDARY OA CHANGES
C1 /C2 JOINT
Endplate irregularity.
SACRO-ILIAC JOINT
A. Uniform Loss of Joint Space. Despite the loss of joint space, the distinct
absence of subchondral sclerosis and diffuse osteopenia.
B. Suprapatellar Effusion.Observe the bulging soft tissue density owing to
effusion (arrows). A patellar erosion can also be appreciated.
C. Bakers Cyst. Note that on arthrography the extent of the cyst is defined
extending into the popliteal space (arrows). Observe the rupture and dissection of
the rheumatoid cyst into the posterior calf.
BONE SCAN
Whole-body radioisotope scan showing areas of
increase in uptake in the neck, both shoulder
joints, the elbow joints, the left hip, both
knees and ankles
The distribution of disease is shown, but the
changes on this scan are not specific.
Eyes
Keratoconjunctivitis
Sicca syndrome
Scleritis
Episcleritis
Keratitis corneal ulceration
Choroiditis
Retinal vacuities
Episcleral nodules
Lungs
Pleuritis pleural effusions
Pulmonary nodules
Interstitial pulmonary fibrosis
Skin
Rheumatoid nodules
Vasculitis
Interstitial granulomatous dermatitis
Agents that are effective in controlling the signs and symptoms of RA, but have no
effect on disease progression
NSAIDs reduce inflammation and pain
COX-2 inhibitors are similar to NSAIDs, but with improved GI safety and tolerability and
higher cardiac side effects
Analgesics- these medicines do not affect inflammation, but work on pain pathways to
decrease subjective feeling of pain.
DMARDs impact the signs, symptoms, and disease progression of RA, as well as improve
the quality of life and functionality of the patient
Irvine S, et al. Ann Rheum Dis. 1999;58:510513; Madhok R, Capell HA. Lancet 1999;353:257258;
ACR Subcommittee on RA Guidelines. Arthritis Rheum. 2002;46:328346; Goldbach-Mansky R, Lipsky PE.
Annu Rev Med. 2003;54:197216.
Biological DMARDS
For example
TNF antagonists
Etanercept (Enbrel)
Adalimumab (Humira)
Infliximab (Remicade)
Certolisumab pegol (Cimzia)
Golimumab (Simponi)
Abatacept (Orencia)
Rituximab (Rituxan)
Tocilizumab (Actemra)
Tofacitinib (Xeljanz)
SLE
RA factor , ANA
SLE
Dermatomyositis
POLYMYOSITIS
CREST SYNDROME (
Calcinosis
Raynauds phenomenon : episodes of intermittent pallor of the fingers and toes
on exposure to cold, secondary to vasoconstriction of the small blood vessels)
Esophageal abnormalities: dilatation and hypoperistalsis
Sclerodactyly
Telengiectasia
30% to 40% of patients have a positive serologic test for rheumatoid factor
and a positive antinuclear antibody (ANA) test.
Bone changes
1.
2.
periarticular osteoporosis
3.
4.
erosions
1.
2.
3.
4.
flexion contractures
1.
2.
In lungs
ESOPHAGEAL DILATATION IS
PATHOGNONOMIC
MCTD
Sjogrens syndrome
And SLE